NCT02137564: Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma |
|
|
| Withdrawn | 2 | 0 | US | gamma secretase inhibitor PF-03084014, PF-03084014, pharmacological study, pharmacological studies, laboratory biomarker analysis | AIDS Malignancy Consortium, National Cancer Institute (NCI), The Emmes Company, LLC | AIDS-related Kaposi Sarcoma, HIV Infection, Recurrent Kaposi Sarcoma | 07/15 | 07/15 | | |
